Condition: Age - Related Macular Degeneration (AMD) · Sponsor: VisionCare, Inc.
This study aims to expand the CE mark IFU of the SING IMT™ to pseudophakic (patients with an intraocular lents) patients with late stage of AMD (Age-Related Macular Degeneration) and bilateral central vision impairment. This randomized, international, multicenter study will evaluate the safety and efficacy of the device in this patient group. Findings will support regulatory submissions, clinical decision-making, and potential label expansion.
This description comes directly from the study's public registry record.
Faustino Vidal Aroca · +39 3476255836 · fvidalaroca@samsaravision.com
Waza Hadjebi · infos@centclin.com
Always discuss trial participation with your own doctor first.
| Centre d'Ophtalmologie Paradis-Monticelli | Marseille, France | Recruiting |
| Hélios Ophtalmologie | Saint-Jean-de-Luz, France | Recruiting |
| CHU de Strasbourg | Strasbourg, France | Recruiting |
| Asklepios Augenklinik Nord-Heidberg | Hamburg, Germany | Recruiting |
| Augenklinik Sulzbach | Sulzbach, Germany | Recruiting |
| MVZ Augenklinik Petrisberg GmbH | Trier, Germany | Recruiting |
| Augenklinik und Poliklinik des Universitätsklinikums | Würzburg, Germany | Recruiting |
| Ospedale Generale Regionale "F. Miulli" | Bari, Italy | Recruiting |
| IRCCS Humanitas | Bergamo, Italy | Recruiting |
| Azienda Ospedaliero-Universitaria di Ferrara | Ferrara, Italy | Recruiting |
| Presidio Ospedaliero Palagi | Florence, Italy | Recruiting |
| Policlinico Universitario Fondazione Agostino Gemelli | Roma, Italy | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07164378